Treatment changes and emotions in multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at how switching or failing multiple sclerosis (MS) treatments affects your feelings and daily life. It may help doctors better support people with relapsing-remitting MS.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have relapsing-remitting MS (RRMS) as defined by current criteria.
- You have been on a moderately effective MS treatment for at least 6 months, or on your first highly effective treatment for at least 6 months.
- You have not been on the same treatment for 3 years or more.
- You have not taken strong immunosuppressants or certain second-line treatments before your current one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how multiple sclerosis affects thinking, energy, mood, and behavior. It uses simple tests and questionnaires to understand your unique profile, which may help tailor future care.
This study looks at “subclinical markers,” meaning early or hidden body changes that may show how relapsing-remitting multiple sclerosis (MS) is doing even when symptoms seem mild. It may help researchers find better ways to monitor MS and detect changes sooner.
This study looks at whether people with relapsing-remitting MS can experience symptom flare-ups (relapses) that don't show up on MRI scans. Researchers want to understand if this happens and what it means for your care.
This study looks at whether the amount of MS treatment-related “burden” in the mouth and body affects how well people stick to their disease-modifying therapy. It may help doctors understand which patients are more likely to have trouble following treatment after switching or starting certain MS medicines.
This study looks at whether a nurse‑coordinated questionnaire can help monitor MS relapses. If you have relapsing-remitting or active secondary progressive MS and are followed by Dr. Manchon, you may be eligible.
This study looks at how multiple sclerosis (MS) affects your thinking, sleep, and tiredness. It compares people with MS who have at least mild fatigue to people without MS who also have sleep problems, to understand these issues better.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.